Effectiveness of the Swedish National Tobacco Quitline
Launched by UPPSALA UNIVERSITY · Mar 10, 2014
Trial Information
Current as of April 24, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tobacco users calling the SNTQ to discuss his/her own tobacco behaviour.
- • The client gives verbal consent to sign up for cessation support.
- • The client return a registration form including a baseline questionnaire
- Exclusion Criteria:
- • Snuff cessation
Trial Officials
Hans Gilljam, Prof
Principal Investigator
Karolinska Institutet
Ásgeir R Helgason, Assoc prof
Principal Investigator
Karolisnka Institutet
Eva Nohlert, PhD
Principal Investigator
Centre for Clinical Research Västerås, Uppsala University
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Stockholm, , Sweden
Västerås, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
